Amgen today announced a $650 million expansion of its U.S. manufacturing network, creating hundreds of new jobs.
The planned investment will support increased drug production at the company's biologics manufacturing facility in Juncos and integrate advanced technologies throughout the operations process. It is expected to create nearly 750 jobs, including construction roles and new skilled manufacturing jobs.
"This expansion underscores Amgen's commitment to U.S. biomanufacturing and to strengthening the resilience of our global supply chain," said Amgen CEO Robert A. Bradway in a statement. "By growing our capacity to deliver innovative medicines with cutting edge technology in our manufacturing plants, we will not only better serve patients but also create high-quality jobs that reinforce America's leadership in biotechnology."
This announcement builds on Amgen's recent investments, including a $600 million science and innovation center in California and manufacturing expansions of $900 million in Ohio and $1 billion in North Carolina, respectively.
